In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharma. In his final blog, Scott looks at whether a single platform could be the way forward for your organization. Informatics platforms have measurable…
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharma. In this second blog, Scott examines the benefits of adopting an integrated platform. It doesn’t matter if you are a large pharma company…
In his three-blog series based on interviews with industry experts, Scott Hluhanich explores the state of pharmaceutical drug development. In this first blog, Scott examines the market challenges and obstacles businesses face when trying to get to market faster. A…
Tip Sheet In this tip sheet, we outline ten things you need to consider before investing in an electronic laboratory notebook. Protect your data and IP The IP that your researchers create is important for patent filing and regulatory submissions…
Following Fierce Biotech’s story revealing $10 million has been raised to bring a $4,000 lab robot into the mainstream, we delve into the driving factors that are required to make process and system automation commonplace in the pharma and biotech…
